Lung adenocarcinoma harboring rare epidermal growth factor receptor L858R and V834L mutations treated with icotinib: A case report

doi:10.12998/wjcc.v8.i17.3841

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4086)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

242

WORD

118

HTML

2216

Figures (1-4)

189

Sum=2765

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

531

Download

790

Sum=1321

Sep 6, 2020 (publication date) through May 19, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Sep 6, 2020; 8(17): 3841-3846
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3841

Full Size Figure Download Figure

Figure 4 Structural analysis of epidermal growth factor receptor L858R and V834L mutants.

Citation: Zhai SS, Yu H, Gu TT, Li YX, Lei Y, Zhang HY, Zhen TH, Gao YG. Lung adenocarcinoma harboring rare epidermal growth factor receptor L858R and V834L mutations treated with icotinib: A case report. World J Clin Cases 2020; 8(17): 3841-3846
URL: https://www.wjgnet.com/2307-8960/full/v8/i17/3841.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i17.3841